Affordable Access

Publisher Website

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma.

Authors
Type
Published Article
Journal
British Journal of Haematology
1365-2141
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
157
Issue
5
Pages
553–563
Identifiers
DOI: 10.1111/j.1365-2141.2012.09099.x
PMID: 22449149
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments